SCHEMBL4747663

SCHEMBL4747663

O=Cc1ccc(OCc2coc(-c3ccccc3)n2)cc1

nearest known ligand 0.63

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 3/20 0.63
PPARA Q07869 4/20 0.59
PPARG P37231 3/20 0.59
ALDH1A1 P00352 4/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
KDM4E B2RXH2 1/20 0.55
LMNA P02545 1/20 0.52
RAB9A P51151 1/20 0.47
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
DRD3 P35462 1/20 0.41
MAPT P10636 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ENPP3 O14638 1/20 0.40
ENPP1 P22413 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4748563 0.87 PPARG (0.49) FFAR1PPARAPPARGALDH1A1SMN1; SMN2
SCHEMBL4747685 0.87 FFAR1 (0.52) FFAR1PPARAPPARGALDH1A1SMN1; SMN2
SCHEMBL4748219 0.86 MAOA (0.56) FFAR1PPARAPPARGRAB9A
SCHEMBL9261947 0.84 PPARG (0.49) FFAR1PPARAPPARGALDH1A1SMN1; SMN2
SCHEMBL9091875 0.84 FFAR1 (0.60) FFAR1PPARAPPARGALDH1A1SMN1; SMN2
SCHEMBL9091876 0.84 FFAR1 (0.60) FFAR1PPARAPPARGALDH1A1SMN1; SMN2
SCHEMBL4744857 0.80 FFAR1 (0.68) FFAR1PPARAPPARGALDH1A1SMN1; SMN2
SCHEMBL4747041 0.80 FFAR1 (0.72) FFAR1PPARAPPARGDRD2DRD4
SCHEMBL6586658 0.80 ALDH1A1 (0.52) FFAR1PPARAPPARGALDH1A1SMN1; SMN2
SCHEMBL5760545 0.80 ALDH1A1 (0.52) FFAR1PPARAPPARGALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008117982-A1 HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR INHIBITING LIPID ACCUMULATION CONTAINING SAME CRYSTAL GENOMICS, INC. (KR) 2008-10-02 WO disclosed
US-7179823-B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-20 US disclosed
EP-1457490-A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity Takeda Chemical Industries, Ltd. (JP) 2004-09-15 EP disclosed
EP-1228067-B1 5-MEMBERED N-HETEROCYCLIC COMPOUNDS WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-07-14 EP disclosed
EP-1228067-A1 5-MEMBERED N-HETEROCYCLIC COMPOUNDS WITH HYPOGYLCEMIC AND HYPOLIPIDEMIC ACTIVITY Takeda Chemical Industries, Ltd. (JP) 2002-08-07 EP disclosed
WO-2001038325-A1 5-MEMBERED N-HETEROCYCLIC COMPOUNDS WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-31 WO disclosed
US-5504097-A TREATING ATHEROSCLEROSIS BY ADMINISTERING AN ANTILIPEMIC OR ANTICHOLESTEROL AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 1996-04-02 US disclosed
US-5459154-A Enzyme inhibitors as antiinflammatory agents and treatment of atherosclerosis AMERICAN HOME PRODUCTS CORPORATION (US) 1995-10-17 US disclosed